Drs. Liisa Selin and Anna Gil have made a monumental breakthrough in the fight against long COVID & ME/CFS with Dr. Salerno’s patented medicine, Inspiritol. This innovative treatment targets CD8 T cells, crucial for immune function, offering new hope and improved symptoms for sufferers.
🔬 Key Insights:
CD8 T cells in affected patients show significant dysfunction, contributing to fatigue and cognitive challenges.
Inspiritol, a novel treatment developed by Dr. Salerno, is making strides in improving these symptoms and restoring CD8 T cell function.
This breakthrough paves the way for better diagnosis and treatment options, bringing hope to millions impacted by long COVID and ME/CFS.
Stay tuned for more updates on this pioneering research!
Click Link Below
https://www.umassmed.edu/news/news-archives/2024/02/umass-chan-advances-research-into-long-covid-myalgic-encephalomyelitis/
